These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2339646)

  • 1. [Instability of the detrusor. Treatment with oxybutynin chloride (Ditropan) in children].
    Vallejo Herrador J; Rodríguez Luna JM; Fernández Fernández A; Perales Cabanas L; Romero Maroto J; Pérez Bustamante I
    Actas Urol Esp; 1990; 14(1):23-7. PubMed ID: 2339646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxybutynin Chloride (Ditrophan)--clinical uses and limitations.
    Brooks ME; Braf ZF
    Paraplegia; 1980 Feb; 18(1):64-8. PubMed ID: 7375129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.
    Franco I; Horowitz M; Grady R; Adams RC; de Jong TP; Lindert K; Albrecht D
    J Urol; 2005 Jan; 173(1):221-5. PubMed ID: 15592080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topical treatment with oxybutynin chloride in neurogenic incontinence].
    López Pereira P; Martínez MJ; Muguerza R; Jaureguizar E
    Cir Pediatr; 1993 Jan; 6(1):29-31. PubMed ID: 8499234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detrusor overactivity in spina bifida: how long does it need to be treated?
    Ab E; Dik P; Klijn AJ; van Gool JD; de Jong TP
    Neurourol Urodyn; 2004; 23(7):685-8. PubMed ID: 15382196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study.
    Madersbacher H; Mürtz G; Alloussi S; Domurath B; Henne T; Körner I; Niedeggen A; Nounla J; Pannek J; Schulte-Baukloh H; Schultz-Lampel D; Bock P; Strugala G
    BJU Int; 2009 Mar; 103(6):776-81. PubMed ID: 19007380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effects of oxybutynin hydrochloride in the treatment of unstable bladder and overactive neurogenic bladder: a long-term clinical trial].
    Goto M; Kato K; Kondo A; Otani T; Takita T; Kobayashi M
    Hinyokika Kiyo; 1988 Mar; 34(3):541-50. PubMed ID: 3389295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
    Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
    Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
    Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
    Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride.
    Bary PR; Moisey CU; Stephenson TP; Brendler CB
    Prog Clin Biol Res; 1981; 78():313-9. PubMed ID: 7038709
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of long-term administration of oxybutynin hydrochloride (KL007) for the treatment of neurogenic bladder and unstable bladder].
    Sonoda T; Sakurai T; Yamada K; Mizutani S; Tsujimoto Y; Ogawa T
    Hinyokika Kiyo; 1989 Jan; 35(1):167-78. PubMed ID: 2658513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of transdermal and oral oxybutynin in children with neurogenic detrusor overactivity.
    Cartwright PC; Coplen DE; Kogan BA; Volinn W; Finan E; Hoel G
    J Urol; 2009 Oct; 182(4):1548-54. PubMed ID: 19683731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia.
    Painter KA; Vates TS; Bukowski TP; Fleming P; Freedman AL; Smith CA; Gonzalez R; Perlmutter AD
    J Urol; 1996 Oct; 156(4):1459-62. PubMed ID: 8808907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination of oxybutynin chloride (Ditropan) with intermittent catheterization in the treatment of neurogenic bladder in childhood: results on continence].
    De Castro R; Casolari E; Ricci S
    Pediatr Med Chir; 1984; 6(6):795-803. PubMed ID: 6545593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Instability of the detrusor muscle. Treatment with oxybutynin chloride (ditropan)].
    Perales Cabanas L; Tallada Buñuel M; Romero Maroto J; Escribano Patiño G
    Actas Urol Esp; 1986; 10(6):481-6. PubMed ID: 3825651
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability.
    Kilic N; Balkan E; Akgoz S; Sen N; Dogruyol H
    Int J Urol; 2006 Feb; 13(2):105-8. PubMed ID: 16563131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with oxybutynin hydrochloride of urinary incontinence and hyperactive bladder conditions in children].
    Aubert D; Cencig P; Royer M
    Ann Pediatr (Paris); 1986 Sep; 33(7):629-34. PubMed ID: 3777773
    [No Abstract]   [Full Text] [Related]  

  • 18. Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin.
    Van Arendonk KJ; Knudson MJ; Austin JC; Cooper CS
    Urology; 2006 Oct; 68(4):862-5. PubMed ID: 17070368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, tolerability, and safety of oxybutynin chloride in pediatric neurogenic bladder with spinal dysraphism: a retrospective, multicenter, observational study.
    Lee JH; Kim KR; Lee YS; Han SW; Kim KS; Song SH; Baek M; Park K
    Korean J Urol; 2014 Dec; 55(12):828-33. PubMed ID: 25512818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.